All Phenotypes B4galnt2<a> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

B4galnt2^a
a variant
MGI:3579307

Summary

1 genotype

Jump to	Allelic Composition	Genetic Background	Genotype ID
cx1	B4galnt2^a/B4galnt2^b Msh2^tm1Htr/Msh2^tm1Htr	involves: 129P2/OlaHsd * BALB/c * SWR	MGI:4429627

Allelic Composition	B4galnt2^a/B4galnt2^b Msh2^tm1Htr/Msh2^tm1Htr
Genetic Background	involves: 129P2/OlaHsd * BALB/c * SWR

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
B4galnt2^a mutation (0 available); any B4galnt2 mutation (27 available)
B4galnt2^b mutation (0 available); any B4galnt2 mutation (27 available)
Msh2^tm1Htr mutation (1 available); any Msh2 mutation (95 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

digestive/alimentary system

decreased enterocyte apoptosis ( J:54082 )

• enterocytes of mice treated with MNNG, temozolomide, and cisplatin exhibit reduced apoptosis compared to cells from similarly treated wild-type mice

• decreased induced apoptosis is not affected by O6-benzylguanine treatment

cellular

decreased enterocyte apoptosis ( J:54082 )

• enterocytes of mice treated with MNNG, temozolomide, and cisplatin exhibit reduced apoptosis compared to cells from similarly treated wild-type mice

• decreased induced apoptosis is not affected by O6-benzylguanine treatment

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/23/2024 MGI 6.23